USPTO serial 87023451
HUMAGINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 1, 2017
- Examiner
- KERTGATE, AMY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with HUMAGINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
CAMILLE M. MILLER COZEN O'CONNOR1650 MARKET STREETSUITE 2800PHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cancer and associated dermatological and immune disorders | SECTION 8 - CANCELLED | — |
| 035 | Business administration of patient reimbursement programs; business administration of pharmacy reimbursement programs and services | SECTION 8 - CANCELLED | — |
| 041 | Providing educational and training services, namely, conducting classes, seminars and workshops in the field of cancer and associated dermatological and immune related disorders; educational services, namely, conducting live and online training in the field of treatment of cancer and associated dermatological and immune related disorders; education services, namely, providing on-line classes, seminars and workshops in the field of cancer and associated dermatological and immune related disorders; arranging and conducting of lectures in the field of cancer and associated dermatological and immune related disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line non-downloadable electronic publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and associated dermatological and immune related disorders; publication of electronic books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials online in the field of cancer and associated dermatological, and immune related disorders; providing online educational games in the field of cancer and associated dermatological and immune related disorders and the treatment thereof | SECTION 8 - CANCELLED | — |
| 042 | Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and associated dermatological and immune related disorders; conducting clinical trials for pharmaceutical products in the field of cancer and associated dermatological and immune related disorders; providing information about the results of clinical trials for pharmaceutical products; providing online non-downloadable software applications containing information on the use of pharmaceutical products and for calculating use of medicine | SECTION 8 - CANCELLED | — |
| 044 | Providing medical information, consultancy and advisory services in the field of health; medical and pharmaceutical consultation; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical counseling; medical services, namely, medical care in the field of cancer and associated dermatological and immune related disorders; planning of medical treatment programs for the treatment of cancer and associated dermatological and immune related disorders; providing information and advice in the fields of cancer and associated dermatological and immune related disorders; providing a web site featuring medical information | SECTION 8 - CANCELLED | — |
| 045 | Personal and social services rendered by others to meet the needs of individuals, namely, providing non-therapeutic emotional counseling and emotional support to patients and families of patients, and providing information to relatives on how to provide emotional support to patients and families of patients | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Celgene Corporation
- Other trademarks owned by Celgene Corporation
- Other trademarks owned by Celgene Corporation
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named HUMAGINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 16, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 1, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 1, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 16, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 16, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 26, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 11, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 6, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 1, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 1, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 22, 2016 | ALIE | ASSIGNED TO LIE | — |
| Nov 3, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 2, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| May 7, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 6, 2016 | NWAP | NEW APPLICATION ENTERED | — |